Andrews RK, Fox JEB (1991) Interaction of purified actin-binding protein with the platelet membrane glycoprotein Ib-IX complex. J. Biol. Chem. 266:7144–7147.

Brooks AR, Blackhart BD, Haubold K, Levy-Wilson B (1991) Characterization of tissue-specific enhancer elements in the second intron of the human apolipoprotein B gene. J. Biol. Chem. 266:7848–7859.

Davis RW, Pierotti VR, Lauer SJ, Hubl ST, McLean JW, Witztum JL, Young SG (1991) Lipoproteins in pinnipeds: Analysis of a high molecular weight form of apolipoprotein E. J. Lipid Res. 32:1013–1023.

Fox JEB, Austin CD, Reynolds CC, Steffen PK (1991) Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J. Biol. Chem. 266:13289–13295.

Friedl W, Ludwig EH, Balestra ME, Arnold KS, Paulweber B, Sandhofer F, McCarthy BJ, Innerarity TL (1991) Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred. Arterioscler. Thromb. 11:371–378.

Friedman G, Liu L, Friedman SL, Boyles JK (1991) Apolipoprotein E is secreted by cultured lipocytes of the rat liver. J. Lipid Res. 32:107–114.

Hussain MM, Maxfield FR, Más-Oliva J, Tabas I, Ji Z-S, Innerarity TL, Mahley RW (1991) Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/a₂-macroglobulin receptor. J. Biol. Chem. 266:13936–13940.

Innerarity TL (1991) Plasma lipoproteins. In: Encyclopedia of Human Biology (Dulbecco R, ed) Academic Press, San Diego, pp 23–35.

Innerarity TL (1991) The role of apolipoprotein E and apolipoprotein B in atherosclerosis. In: Vascular Endothelium. Physiological Basis of Clinical Problems (Catravas JD, Callow AD, Gillis CN, Ryan US, eds) Plenum Press, New York, pp 183–196.

Innerarity TL (1991) The low-density lipoprotein receptor. Curr. Opin. Lipidol. 2:156–161.

Levy-Wilson B, Soria L, Ludwig EH, Argyres M, Brooks AR, Blackhart BD, Friedl W, McCarthy BJ (1991) A polymorphism in a region with enhancer activity in the second intron of the human apolipoprotein B gene. J. Lipid Res. 32:137–145.

Linton MF, Gish R, Hubl ST, Bütler E, Esquivel C, Bry WI, Boyles JK, Wardell MR, Young SG (1991) Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88:270–281.

Ludwig EH, Haubold K, McCarthy BJ (1991) Analysis of two different tandem repetitive elements within the human apolipoprotein B gene. J. Lipid Res. 32:374–379.

Ludwig EH, Levy-Wilson B, Knott T, Blackhart BD, McCarthy BJ (1991) Comparative analysis of sequences at the 5′ end of the human and mouse apolipoprotein B genes. DNA Cell Biol. 10:329–338.

Lund-Katz S, Innerarity TL, Arnold KS, Curtiss LK, Phillips MC (1991) ¹³C NMR evidence that substitution of glutamine for arginine 3500 in familial defective apolipoprotein B-100 disrupts the conformation of the receptor-binding domain. J. Biol. Chem. 266:2701–2704.

Mahley RW (1991) Type III hyperlipoproteinemia (dysbetalipoproteinemia): A genetic disorder associated with premature atherosclerosis. In: Primary Hyperlipoproteinemias (Steiner G, Shafrir E, eds) McGraw-Hill, New York, pp 261–270.

Mahley RW, Bersot TP (1991) Lipid abnormalities: Mechanisms, clinical classifications, and management. In: Cardiology. An Illustrated Text/Reference (Chatterjee K, Cheitlin MD, Karliner J, Parmley WW, Rapaport E, Scheinman M, eds) JB Lippincott, Philadelphia, pp 7.36–7.47.

Mahley RW, Hussain MM (1991) Chylomicron and chylomicron remnant catabolism. Curr. Opin. Lipidol. 2:170–176.

Mahley RW, Weisgraber KH, Innerarity TL, Rall SC Jr (1991) Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism. J. Am. Med. Assoc. 265:78–83.

McCarthy BJ (1991) Polymorphisms and markers associated with apolipoprotein B. Curr. Opin. Lipidol. 2:81–85.

Paulweber B, Brooks AR, Nagy BP, Levy-Wilson B (1991) Identification of a negative regulatory region 5′ of the human apolipoprotein B promoter. J. Biol. Chem. 266:21956–21961.

Paulweber B, Levy-Wilson B (1991) The mechanisms by which a human apolipoprotein B gene enhancer and reducer interact with the promoter are different in cultured cells of hepatic and intestinal origin. J. Biol. Chem. 266:24161–24168.

Paulweber B, Onasch MA, Nagy BP, Levy-Wilson B (1991) Similarities and differences in the function of regulatory elements at the 5′ end of the human apolipoprotein B gene in cultured hepatoma (HepG2) and colon carcinoma (CaCo-2) cells. J. Biol. Chem. 266:24149–24160.

Simonet WS, Bucay N, Pitas RE, Lauer SJ, Taylor JM (1991) Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J. Biol. Chem. 266:8651–8654.

Steiner B, Parise LV, Leung B, Phillips DR (1991) Ca²⁺-dependent structural transitions of the platelet glycoprotein IIb-IIIa complex. Preparation of stable glycoprotein IIb and IIa monomers. J. Biol. Chem.266:14986–14991.

Tabas I, Myers JN, Innerarity TL, Xu X-X, Arnold K, Boyles J, Maxfield FR (1991) The influence of particle size and multiple apoprotein E–receptor interactions on the endocytic targeting of b-VLDL in mouse peritoneal macrophages. J. Cell Biol. 115:1547–1560.

Taylor JM, Simonet WS, Bucay N, Lauer SJ, de Silva HV (1991) Expression of the human apolipoprotein E/apolipoprotein C-I gene locus in transgenic mice. Curr. Opin. Lipidol. 2:73–80.

Wardell MR, Rall SC Jr, Schaefer EJ, Kane JP, Weisgraber KH (1991) Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity. J. Lipid Res. 32:521–528.

Weis JR, Pitas RE, Wilson BD, Rodgers GM (1991) Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J. 5:2459–2465.

Weisgraber KH, Shinto LH (1991) Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J. Biol. Chem. 266:12029–12034.

Welty FK, Hubl ST, Pierotti VR, Young SG (1991) A truncated species of apolipoprotein B (B67) in a kindred with familial hypobetalipoproteinemia. J. Clin. Invest. 87:1748–1754.

Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252:1817–1822.

Yao Z, Blackhart BD, Linton MF, Taylor SM, Young SG, McCarthy BJ (1991) Expression of carboxyl-terminally truncated forms of human apolipoprotein B in rat hepatoma cells. Evidence that the length of apolipoprotein B has a major effect on the buoyant density of the secreted lipoproteins. J. Biol. Chem. 266:3300–3308.

Young SG, Linton MF (1991) Genetic abnormalities in apolipoprotein B. Trends Cardiovasc. Med. 1:59–65.

TOP